Design of Novel Benzothiazole-Based Succinate Dehydrogenase Inhibitors Inspired by Polyrhachis dives: Structural Optimization, Potential Fungicidal Activity, and Mechanistic Insights.

Inspired by benzothiazole derivatives with bioactivity from Polyrhachis dives, 33 benzothiazole-based acetamide derivatives were designed and synthesized via structural optimization, incorporating aryl sulfide fragments and saturated six-membered aza-heterocycles. Among them, compounds JSZ16 and JSZ28 exhibited potent broad-spectrum fungicidal activity in vitro, with median effective concentration (EC50) values of 4.4 and 8.5 mg/L against Sclerotinia sclerotiorum, respectively, comparable to boscalid (EC50 = 2.4 mg/L). In vivo assays further demonstrated the protective efficacy of JSZ16 (77.6% at 200 mg/L) on rape leaves, albeit with limited curative effects. Mechanistic studies confirmed that JSZ16 influences the cell membrane permeability of pathogenic fungi. Besides, the enzymatic activity assay demonstrated that JSZ16 (IC50 = 30.3 μM) effectively inhibited succinate dehydrogenase (SDH) activity, with its activity level being comparable to that of boscalid (IC50 = 24.8 μM). Molecular docking analysis revealed that JSZ16 and JSZ28 shared a conserved binding mode with SDH, displaying a similar interaction pattern observed for the boscalid. Acute toxicity tests in mice revealed no significant adverse effects, underscoring the safety profile of JSZ16. This work presents benzothiazole-based SDH inhibitors as promising candidates for combating fungal pathogens with considerable efficacy and low toxicity.